Download from app store
We have detected that you are using an Ad Blocker.
PracticeUpdate is free to end users but we rely on advertising to fund our site. Please consider supporting PracticeUpdate by whitelisting us in your ad blocker.
We have sent a message to the email address you have provided, . If this email is not correct, please update your settings with your correct address.
The email address you provided during registration, , does not appear to be valid. Please update your settings with a valid address before to continue using PracticeUpdate.
Please provide your AHPRA Number to ensure that you are given the correct level of access to our site.
featured
Published in Dermatology

Journal Scan / Research · May 19, 2015

Tumor Thickness and Adnexal Extension of Superficial Basal Cell Carcinoma as Determinants of Noninvasive Treatment Failure

Journal of the American Academy of Dermatology

 

Additional Info

Journal of the American Academy of Dermatology
Tumor Thickness and Adnexal Extension of Superficial Basal Cell Carcinoma (sBCC) as Determinants of Treatment Failure for Methylaminolevulinate (MAL)-Photodynamic Therapy (PDT), Imiquimod, and 5-Fluorouracil (FU)
J Am Acad Dermatol 2015 Apr 30;[EPub Ahead of Print], MH Roozeboom, L van Kleef, AH Arits, K Mosterd, VJ Winnepenninckx, AM van Marion, PJ Nelemans, NW Kelleners-Smeets

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.

Further Reading